The risk of musculoskeletal adverse outcomes after treatment with endocrine blocking treatments for breast cancer (MSKAI)

First published 09/12/2020

Last updated 22/02/2024

EU PAS number:

EUPAS38362

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

MSK_AI_Protocol_1.4 for EU PAS

English (905.49 KB - PDF)View document

Updated protocol

MSK_AI_Protocol_1.5 for EU PAS

First published: 22/02/2024

English (905.41 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents